The relevance of SPARC in the hallmarks of bladder cancer was determined using a carcinogen-induced model providing a tobacco metabolite and chemical carcinogen N-nitrosobutyl(4-hydroxybutyl)amine (BBN) to SP−/− and SP+/+ mice for ∼ 40 weeks. Here, TFF2 is linked to urinary bladder carcinoma.